News
Important Only
CNS Pharmaceuticals Inc expected to post a loss of $9.60 a share - Earnings Preview
CNS Pharmaceuticals Inc CNSP.OQ CNSP.O is expected to report resultson August 12 (estimated) for the period ending June 30 2025LSEG's mean analyst estimate for CNS Pharmaceuticals Inc is for a loss of $9.60 per share. The current average analyst rating on the shares is "buy" and the br...Reuters
Fri, Aug 8
TV broadcaster Nexstar in advanced talks to acquire rival Tegna, source says
A deal between Nexstar and Tegna can be finalised soon, a source saysTegna shares jumped 30% after the report; Nexstar’s stock was flatA deal could accelerate industry consolidation amid expected FCC deregulationBy Milana VinnAug 8 (Reuters) - Television broadcaster Nexstar Media Group NXST.O is in ...Reuters
Fri, Aug 8
BitMine Stock Surges 62% This Week As Company Becomes World's Largest Ethereum Holder
Shares of Bitmine Immersion Technologies Inc BMNR soared more than 62% this week, propelled by the firm’s ongoing strategic pivot to build an Ethereum ETH/USD treasury. Here’s what investors need to know.What To Know: BitMine earlier this week announced it has accumulated 833,137 ETH, valued at near...Tiger News
Fri, Aug 8
Why Rocket Lab Stock Skyrocketed Today but Fell Back to Earth
Key PointsRocket Lab stock was up as much as 12.9% in today's trading, but it saw a big pullback.The company's second-quarter results delivered sales that far exceeded Wall Street's target. Rocket Lab also posted a larger-than-expected loss in the second quarter, and the company's growth-dependent v...The Motley Fool
Fri, Aug 8
Pulse Biosciences Inc expected to post a loss of 26 cents a share - Earnings Preview
Pulse Biosciences Inc PLSE.OQ PLSE.O is expected to report resultson August 12 for the period ending June 30 2025LSEG's mean analyst estimate for Pulse Biosciences Inc is for a loss of 26 cents per share. The one available analyst rating on the shares is "strong buy". The average cons...Reuters
Fri, Aug 8
Rein Therapeutics Inc expected to post a loss of 22 cents a share - Earnings Preview
Rein Therapeutics Inc RNTX.OQ RNTX.O is expected to show no change in quarterly revenue when it reports results on August 12 (estimated) for the period ending June 30 2025LSEG's mean analyst estimate for Rein Therapeutics Inc is for a loss of 22 cents per share. The one available analyst rati...Reuters
Fri, Aug 8
Why Novo Nordisk Stock Flew Higher on Friday
Key PointsAn archrival's investigational obesity drug didn't perform spectacularly in a recent clinical study.Its results lagged that of Novo Nordisk's star product, Wegovy.10 stocks we like better than Novo Nordisk › On Friday, the stock of Novo Nordisk (NYSE: NVO) continued to be affected by resul...The Motley Fool
Fri, Aug 8
DoorDash: A $100 Billion Delivery Giant Under the Microscope
Explore the exciting world of DoorDash (NASDAQ: DASH) with our contributing expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market trends and potential investment opportunities!*Stock prices used were the prices of Jul. 16, 2025. The v...The Motley Fool
Fri, Aug 8
GCT Semiconductor Holding Inc expected to post a loss of 14 cents a share - Earnings Preview
GCT Semiconductor Holding Inc GCTS.N, GCTS.K is expected to report resultson August 12 for the period ending June 30 2025The San Jose California-based company is expected to report revenue of $2.3 million, according to the estimate from one analyst, based on LSEG data.LSEG's mean analyst esti...Reuters
Fri, Aug 8
Plains GP Touts Asset Sale in Q2 Results
Plains GP Holdings(NASDAQ:PAGP) reported second-quarter 2025 adjusted EBITDA of $672 million and announced a $3.75 billion divestiture of its NGL business to Keyera, with closing expected in 2026. Management reaffirmed full-year 2025 adjusted EBITDA guidance of $2.8 billion to $2.95 billion and high...The Motley Fool
Fri, Aug 8
Why Tempus AI Stock Jumped Today
Key PointsTempus AI beat Wall Street's sales and earnings targets in the second quarter. The company posted a big sales beat in the second quarter, and management increased the company's full-year sales target. Tempus AI also looks poised to record a big improvement this year. 10 stocks we like bett...The Motley Fool
Fri, Aug 8
Constellation Software Inc reports results for the quarter ended June 30 - Earnings Summary
Constellation Software Inc CSU.TO reported quarterly adjusted earnings of $23.87 per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of $17.89. The mean expectation of eight analysts for the quarter was for earnings of $22.11 per share. W...Reuters
Fri, Aug 8
Plains All American Pipeline Reaffirms Guidance
Plains All American Pipeline (NASDAQ:PAA) reported adjusted EBITDA of $672 million for Q2 2025 and reaffirmed its full-year 2025 EBITDA guidance of $2.8 billion to $2.95 billion. The company announced in June 2025 the approximately $3.75 billion sale of its Canadian NGL business to Keyera, an expand...The Motley Fool
Fri, Aug 8
Essent Group Posts $195 Million Profit
Essent Group(NYSE:ESNT) reported second-quarter 2025 results on Aug. 8, 2025, with GAAP net income of $195 million, diluted EPS of $1.93, and annualized return on average equity of 14%. Insurance in force reached $247 billion (up 3% year over year) as of June 30, 2025, and persistency was 85.8%. The...The Motley Fool
Fri, Aug 8
Why Nektar Therapeutics Stock Popped 6% on Friday
Key PointsInvestors were reacting to the biotech's second-quarter earnings report.Revenue was higher than analysts expected, although the net loss was deeper than the consensus.10 stocks we like better than Nektar Therapeutics › Biotech Nektar Therapeutics (NASDAQ: NKTR) unveiled its latest quarterl...The Motley Fool
Fri, Aug 8
Immix Biopharma Inc expected to post a loss of 16 cents a share - Earnings Preview
Immix Biopharma Inc IMMX.OQ IMMX.O is expected to report results on August 11 (estimated) for the period ending September 30 2025LSEG's mean analyst estimate for Immix Biopharma Inc is for a loss of 16 cents per share. The one available analyst rating on the shares is "buy". The mean ...Reuters
Fri, Aug 8
Why SoundHound AI Stock Skyrocketed Today
Key PointsSoundHound AI reported its second-quarter results yesterday and beat Wall Street's sales and earnings targets. The software specialist's sales momentum was very strong in the quarter, and the company raised its full-year sales outlook. SoundHound AI is set to record huge sales growth this ...The Motley Fool
Fri, Aug 8
Spero Therapeutics Inc expected to post a loss of 38 cents a share - Earnings Preview
Spero Therapeutics Inc SPRO.OQ SPRO.O is expected to show a fall in quarterly revenue when it reports results on August 12 for the period ending June 30 2025LSEG's mean analyst estimate for Spero Therapeutics Inc is for a loss of 38 cents per share. The current average analyst rating on the s...Reuters
Fri, Aug 8
Why Integral Ad Science's Stock Crushed the Market on Friday
Key PointsAll three revenue categories for the company saw year-over-year rises in its latest reported quarter.With that, it wasn't too hard for the company to score beats on both revenue and profitability.10 stocks we like better than Integral Ad Science › The stock of digital advertising analysis ...The Motley Fool
Fri, Aug 8
Lument Finance Trust Inc reports results for the quarter ended June 30 - Earnings Summary
Lument Finance Trust Inc LFT.N reported quarterly adjusted earnings of 5 cents per share for the quarter ended June 30, lower than the same quarter last year, when the company reported EPS of 9 cents. The mean expectation of two analysts for the quarter was for earnings of 8 cents per share. Wall...Reuters
Fri, Aug 8
